Kilitch Drugs (India) Ltd (KILITCH) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 189669, "name": "Kilitch Drugs", "stock_name": "Kilitch Drugs", "full_name": "Kilitch Drugs (India) Ltd", "name_url": "stocks-analysis/kilitch-drugs", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "213.20", "chg": 10.15, "chgp": "5.0%", "dir": 1, "prev_price": "203.05", "mcapval": "745.00 Cr", "mcap": "Micro Cap", "scripcode": 524500, "symbol": "KILITCH", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE729D01010", "curr_date": "Sep 22, 03:30 PM", "curr_time": "03:48 AM", "last_traded_at": "Sep 22, 03:30 PM IST", "bse_nse_vol": "45.88 k", "exc_status": "Active", "traded_date": "Sep 22, 2026", "traded_date_str": "2026 09 22", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/kilitch-drugs-189669-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Kilitch Drugs Locks at Upper Circuit With 5.0% Gain — Buyers Queue, Sellers Absent", "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-india-ltd-surges-to-upper-circuit-amid-robust-buying-pressure-4200969", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/KilitchDrugsInd_stocks_hitting_upper_circuit_4200969.png", "date": "2026-09-22 10:00:08", "description": "At Rs 211.07, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Kilitch Drugs (India) Ltd locked at its upper circuit of 5.0% on 22 Sep 2026, with buyers queuing and no sellers willing to part with shares." }, { "title": "Kilitch Drugs (India) Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent", "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-india-ltd-hits-upper-circuit-amid-strong-buying-pressure-4200021", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/KilitchDrugsInd_stocks_hitting_upper_circuit_4200021.png", "date": "2026-09-21 13:00:06", "description": "At Rs 201.02, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Kilitch Drugs (India) Ltd locked at its upper circuit of 5% on 21 Sep 2026, with buyers queuing and no sellers willing to part with shares." }, { "title": "Kilitch Drugs (India) Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/kilitch-drugs-india-ltd-is-rated-sell-4199625", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/KilitchDrugsInd_mojoScore_4199625.png", "date": "2026-09-21 10:11:31", "description": "Kilitch Drugs (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Kilitch Drugs Gains 6.57%: 3 Key Factors Driving the Week’s Rally", "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-gains-657-3-key-factors-driving-the-weeks-rally-4192195", "imagepath": "", "date": "2026-09-13 14:00:42", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>31 Aug:</strong> Stock opens week with a 3.55% gain to ₹175.00</p>\n <p><strong>1 Sep:</strong> Valuation shifts to fair amid sector comparisons</p>\n <p><strong>2 Sep:</strong> Technical momentum turns mildly bearish with mixed signals</p>\n <p><strong>4 Sep:</strong> Stock surges to upper circuit, closing at ₹180.10 (+4.98%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">₹169.00</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">₹180...." }, { "title": "Kilitch Drugs (India) Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/kilitch-drugs-india-ltd-is-rated-sell-4187722", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/KilitchDrugsInd_mojoScore_4187722.png", "date": "2026-09-09 10:11:39", "description": "Kilitch Drugs (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 September 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Kilitch Drugs (India) Ltd Technical Momentum Shifts Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-india-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4184412", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/KilitchDrugsInd_technicaldot_4184412.png", "date": "2026-09-07 08:00:31", "description": "Kilitch Drugs (India) Ltd has experienced a notable shift in its price momentum, moving from a mildly bearish to a mildly bullish technical trend. Despite a recent downgrade in its Mojo Grade to Sell from Hold, the stock’s technical indicators present a complex picture, with some signals suggesting potential upside while others remain cautious. This article analyses the latest technical parameters, price movements, and relative performance against the Sensex to provide a comprehensive view for investors." }, { "title": "Kilitch Drugs (India) Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent", "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-india-ltd-surges-to-upper-circuit-amid-robust-buying-pressure-4182803", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/KilitchDrugsInd_stocks_hitting_upper_circuit_4182803.png", "date": "2026-09-04 15:00:09", "description": "At Rs 181.14, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Kilitch Drugs (India) Ltd locked at its upper circuit of 5% on 4 Sep 2026, with buyers queuing and no sellers willing to part with shares." }, { "title": "Kilitch Drugs (India) Ltd Technical Momentum Shifts Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-india-ltd-technical-momentum-shifts-amid-mixed-market-signals-4178389", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/KilitchDrugsInd_technicaldot_4178389.png", "date": "2026-09-02 08:01:06", "description": "Kilitch Drugs (India) Ltd has experienced a subtle but notable shift in its technical momentum, moving from a mildly bullish stance to a mildly bearish outlook. Despite a modest decline in price and a downgrade in its Mojo Grade to Sell, the stock’s long-term returns remain impressive compared to the broader market, signalling a complex technical and fundamental landscape for investors to navigate." }, { "title": "Kilitch Drugs Valuation Shifts to Fair Amidst Sector Comparisons and Market Performance", "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-valuation-shifts-to-fair-amidst-sector-comparisons-and-market-performance-4176577", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/KilitchDrugsInd_valuationdot_4176577.png", "date": "2026-09-01 08:00:08", "description": "Kilitch Drugs (India) Ltd has experienced a notable shift in its valuation parameters, moving from a previously very attractive rating to a fair valuation grade. This change reflects evolving market perceptions amid a competitive pharmaceutical sector, with the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now aligning more closely with sector peers. Investors should carefully analyse these valuation adjustments in the context of Kilitch’s financial performance and broader industry trends." } ], "total": 374, "sid": "189669", "stock_news_url": "https://www.marketsmojo.com/news/kilitch-drugs-india-189669" }, "announcements": [ { "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report", "datetime": "27-Aug-2026", "details": "We are submitting herewith the scrutinizers report for the voting process of 34th Annual General Meeting of Kilitch Drugs India Limited", "source": "BSE" }, { "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM", "datetime": "27-Aug-2026", "details": "We are submitting herewith the proceeding of 34th Annual General Meeting", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "18-Aug-2026", "details": "We are submitting herewith the publication of extract of the financial results for the quarter ended 30th June 2026", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Kilitch Drugs (India) Ltd has declared <strong>5%</strong> dividend, ex-date: 20 Sep 19", "dt": "2019-09-20", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Kilitch Drugs (India) Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 24 Mar 26", "dt": "2026-03-24", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "", "data": [ { "txt": "Kilitch Drugs (India) Ltd has announced <strong>2:23</strong> rights issue, ex-date: 15 Jul 25", "dt": "2025-07-15", "middle_text": "Rights Issue" } ] } ] }

Key Events This Week

31 Aug: Stock opens week with a 3.55% gain to ₹175.00

1 Sep: Valuation shifts to fair amid sector comparisons

2 Sep: Technical momentum turns mildly bearish with mixed signals

4 Sep: Stock surges to upper circuit, closing at ₹180.10 (+4.98%)

Read full news article

Kilitch Drugs (India) Ltd is Rated Sell

2026-09-09 10:11:39

Kilitch Drugs (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 September 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Kilitch Drugs (India) Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-09-07 08:00:31

Kilitch Drugs (India) Ltd has experienced a notable shift in its price momentum, moving from a mildly bearish to a mildly bullish technical trend. Despite a recent downgrade in its Mojo Grade to Sell from Hold, the stock’s technical indicators present a complex picture, with some signals suggesting potential upside while others remain cautious. This article analyses the latest technical parameters, price movements, and relative performance against the Sensex to provide a comprehensive view for investors.

Read full news article

Kilitch Drugs (India) Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent

2026-09-04 15:00:09

At Rs 181.14, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Kilitch Drugs (India) Ltd locked at its upper circuit of 5% on 4 Sep 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

Kilitch Drugs (India) Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-09-02 08:01:06

Kilitch Drugs (India) Ltd has experienced a subtle but notable shift in its technical momentum, moving from a mildly bullish stance to a mildly bearish outlook. Despite a modest decline in price and a downgrade in its Mojo Grade to Sell, the stock’s long-term returns remain impressive compared to the broader market, signalling a complex technical and fundamental landscape for investors to navigate.

Read full news article

Kilitch Drugs Valuation Shifts to Fair Amidst Sector Comparisons and Market Performance

2026-09-01 08:00:08

Kilitch Drugs (India) Ltd has experienced a notable shift in its valuation parameters, moving from a previously very attractive rating to a fair valuation grade. This change reflects evolving market perceptions amid a competitive pharmaceutical sector, with the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now aligning more closely with sector peers. Investors should carefully analyse these valuation adjustments in the context of Kilitch’s financial performance and broader industry trends.

Read full news article